MS PHARMA

MS Pharma is a leading pharmaceutical company and partner of choice in Europe, the Middle East, Africa and Turkey. The company has over 2,700 employees, a presence in 13 countries and actively sells its products in over 70 countries around the world with a capacity of 600 million boxes per year. MS Pharma is headquartered in Jordan and has R&D and manufacturing facilities in Greece, Algeria, Jordan, Saudi Arabia and Turkey and manufactures several dosage forms including solids, liquids, cytotoxics and sterile injectables. The company markets a wide range of generic and biotech products in the MENA region and is active in several therapeutic areas, including cardiovascular, CNS, respiratory and Oncology. Through its subsidiary, Genepharm, the company is also engaged in the development, manufacturing and out-licensing of quality generic pharmaceuticals, and among its customers are the world’s leading pharmaceutical companies. MS Pharma is committed to offer high quality generic medicines with added value by basing its production on new technologies and state-of-the-art facilities implemented all around the META and Europe region. MS Pharma is also one of the first-movers towards new generation biotech and biosimilars in which the company has acquired a considerable expertise and know-how across the region. MS Pharma aims to grow into the leading generic pharmaceutical and healthcare company in MENA region by targeting strategic therapeutic classes and formulations with higher entry barriers.